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Abstract: The development of nanotechnology is responsible for an increase in the 
achievements in medical diagnostics and in the preparation of new therapeutic vehicles. In 
particular, magnetic nanoparticles with a modified surface are a very attractive alternative 
to deliver therapeutic agents. We describe the modification of the surface of the  
iron oxide nanoparticles with aminophosphonic acids by applying the classic 
hydrophosphonylation approach. 
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1. Introduction 
The dynamic development of nanotechnology (including nanoparticle technology) and molecular 
biology is the cause of a rapid increase in the achievements in medical diagnostics and in the 
preparation of new therapeutic substances [1–3]. Nanoparticles with a suitably chemically modified 
surface may be used for many applications, such as magnetic resonance imaging contrast 
enhancement, immunoassay, detoxification of biological fluids, drug delivery devices, and in cell 
separation [4,5]. Magnetic nanovehicles are especially very attractive for the delivery of therapeutic 
agents. They can be targeted to specific locations in the body through the application of an external 
magnetic field gradient, as has been documented by a number of promising animal and clinical trials [6–8]. 
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In this paper we describe the usefulness of hydro-phosphonylation of the C=N bond for the 
modification of the surface of the iron oxide nanoparticles with aminophosphonic acids. Such 
aminophosphonate nanoparticles should act as interesting, surfactant-like species because depending 
on the pH of the solution, they may appear as negatively (because of the presence of phosphonate 
groups in their structure), positively (because of the presence of ammonium groups) or zwitterionic species, 
thus being able to exhibit non-typical properties, similar to those of recently obtained gold-supported 
negatively charged surfactant-like nanoparticles [9]. This property should facilitate their ability to bind 
organic compounds, proteins and metal ions.  
The combination of the biological properties of aminophosphonates [10,11] and the potential of the 
magnetic nanoparticles for effective targeted delivery using an external magnetic force, should lead to 
magnetic bio-conjugates for selective targeting of physiologically active aminophosphonates to organs 
which require their activity. The nanoparticles covered with aminophosphonates may also be  
used as the supports for the immobilization of other drugs (especially anticancer ones) or for the 
immobilization of enzymes. Additionally, they can be considered as a system for the removal of metal 
ions from environmental and body fluids [12]. This could be achieved because aminophosphonic acids 
are bifunctional molecules and possess two reactive moieties—amino and phosphonate groups. Thus, 
when present at the surface of nanoparticles they could be used to bind other substances (including 
proteins) either covalently or by adsorption. This property should facilitate their ability to bind organic 
compounds, proteins and metal ions. In this paper we describe our preliminary studies on the 
modification of superparamagnetic iron oxide nanoparticles with aminophosphonic acids 
2. Results and Discussion 
2.1. Preparation of Modified Nanoparticles 
Iron oxide nanoparticles obtained by the standard co-precipitation method from iron(II) and 
iron(III) chlorides in the presence of ammonium hydroxide solution [13], were coated with tetraethyl 
orthosilicate and their surface was further functionalized with (3-aminopropyl)triethoxysilane 
(APTMS) [14]. 
Magnetic iron oxide nanoparticles coated with structurally variable aminophosphonates have been 
obtained by hydrophosphonylation of Schiff bases. We have applied its reacted version commonly 
used in aminophosphonate synthesis [15]. The direct application of this procedure when  
(3-aminopropyl)-triethoxysilane functionalized nanoparticles were used gave unsatisfactory results, 
because of strong aggregation of the resulting nanoparticles. This might be due to the high density of 
amino groups on the nanoparticles’ surface and their simultaneous low flexibility. Therefore, we 
decided to apply the double-functionalization approach using aminopyridine or diaminopyrimidine as 
linkers. The synthetic procedure, schematically shown in Figure 1, provided two series of 
nanoparticles 1a–j and 2d and 2g. Finally, one phosphonate moiety was hydrolyzed with sodium 
iodide in acetone followed by acidification with 1M hydrochloric acid, a reaction which provided 
nanoparticles functionalized with aminophosphonate esters. Finally, one phosphonate moiety was 
desterilized with sodium iodide in acetone followed by acidification with 1M hydrochloric acid, a 
reaction which provided nanoparticles functionalized with aminophosphonate esters. Hydrolysis to 
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monoester is of strategic importance—in further studies, the resulting compound library will be used to 
further immobilization, including enzymes. 
Figure 1. Synthetic scheme leading to aminophosphonate-functionalized magnetic nanoparticles. 
 
2.2. Characterization of Nanoparticles 
The formation of functionalized nanoparticles is accompanied by the sharpening of the IR spectra, 
which is in good accordance with the literature [16,17]. The infrared spectra of unmodified and 
aminophosphonate-modified iron oxide nanoparticles are shown in Figure 2. The IR spectrum of pure 
iron oxide nanoparticle shows a strong and wide band around 580 cm−1, characteristic for the Fe–O 
stretching vibrations related to the magnetic core [Figure 2(a)]. A broad peak at around 1,078 cm−1 
corresponds to the Si-O and Si-C antisymmetric out of plane stretching bands, which are overlapping 
[Figure 2(b)]. Binding of aminophosphonate results in significant changes in the spectra [Figure 2(c)]. 
They are similar to those which are expected for aminophosphonates. The presence of P=O results in 
the stretching band at 1,230 cm−1, whereas the peak at 1,030 cm−1 corresponds to both P-O-C and Ar-O-C 
vibrations (the latter one in the particular cases of particles 1g and 1j). The peak at 1,600 cm−1 most 
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likely corresponds to the N-H bending scissoring vibrations, while C-N bond stretching is seen at 
1,480 cm−1. 
Figure 2. IR spectra of (a) iron oxide nanoparticle; (b) nanoparticle coated with silica and 
functionalized with APTMS; (c) aminophosphonate-functionalized nanoparticle 1g.  
 
In order to determine if there is a phosphorus atom present at the surface of the obtained 
nanoparticles we have applied energy-dispersive X-ray spectroscopy (SEM-EDX), which gave 
expected results (Figure 3). During sample scanning the obtained bands clearly showed the presence of 
the following atoms: Fe (6.5 and 0.8 KeV), Si (1.9 KeV), P (2.0KeV), O (0.5KeV) and C (0.1 KeV). 
Intensified signals at 0.1, 0.3, 2.5 are derived from elements contained in the matrix: C (0.1 KeV) and 
Cl (0.3 KeV, 2.5 KeV). 
Due to the magnetic properties of iron oxide nanoparticles we could not apply 31P-NMR, a 
technique typically used for the determination of the presence of carbon-to-phosphorus bonds. 
Therefore we have decided to obtain pure silica oxide nanoparticles and functionalize their surface 
with representative aminophosphonates in a manner identical to the magnetic ones. We expected that 
the infrared spectra of these nanoparticles were going to be similar to those obtained for functionalized 
magnetic nanoparticles showing only the lack of the band corresponding to the Fe-O vibrations.  
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Figure 3. EDX spectrum of 1g nanoparticles. 
 
On the other hand, the fact that this system is not magnetic allows us to perform 31P-NMR 
measurements. The silica nanoparticles, lacking the iron oxide magnetic core, were synthesized from 
tetraethylortosilicate following the procedure described in the literature. In the next step we modified 
their surfaces with (3-aminopropyl)-trimethoxysilane and then with aminophosphonates following the 
procedure elaborated in this work. The IR spectra received for these particles, lacking the magnetic 
core, were identical to those obtained for magnetic ones. The 31P-NMR spectra obtained for the 
nanoparticles clearly indicated the presence of a phosphonate moiety appearing at about 20 ppm, which 
corresponded to the expected products (Figure 4). This finding unequivocally confirms that the procedure 
described in this paper results in iron oxide nanoparticles surface covered with aminophosphonates. 
Between 5 and 10 ppm additional peaks corresponding to diethyl and monoethyl phosphites could be 
observed. Their appearance results from the fact that we had not purified the functionalized silica. 
Figure 4. (a) 31P-NMR spectrum of nanoparticle 1g lacking magnetic core (b) Comparison 
of IR spectrum with magnetic core (blue line) and without (red line) of nanoparticles 
modified with 2,6-diamino-4-chloropyrimidine. 
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2.3. Nanoparticles Size and Dispersion 
The size and distribution of oxide nanoparticles have been measured using dynamic light scattering. 
The size distribution of non-functionalized iron oxide nanoparticles, is between 15–50 nm, with a 
maximum value at 32 nm (Figure 5). The size distribution of functionalized particles clearly shows 
that they have a strong tendency to agglomerate. This is clearly seen from the transmission electron 
microscopy measurements (TEM), which support both the nearly uniformly sized uncoated iron oxide 
and the wide distribution of the size of the functionalized ones results from aggregation. The degree of 
aggregation is dependent on the structure of nanoparticle coating (presence or absence of linker), the 
structure of the aminophosphonate side chain and on the solvent used (measurements were done in 
water, methanol, toluene and acetone). The measurements indicated that the average diameter of the 
obtained nanoparticles appeared to be the smallest in methanol, with compounds 1a (hydrodynamic 
size 144 nm), 1c (72 nm), 1f (70 nm), 1i (65 nm) and 1j (139nm) being representative examples. The 
respective acids 1a, 1c, 1d, 4d and 4g also exhibit low size of dispersion of 50–200 nm.  
Figure 5. DLS measurements of iron oxide nanoparticles (red line) and with silica core 
(blue line).  
 
The measurements in acetone also gave satisfactory results—some nanoparticles (1f, 1c and 5b) 
exhibit a low range of size dispersion, whereas others yielded quite large aggregates, while in toluene 
mostly highly aggregated particles were observed. It is also worth noting that nanoparticles after 
hydrolysis 3a–j gave the best results in acetone. It is not possible to draw any meaningful  
size-dispersion—structure relationship for these species from these results. In Table 1 all DLS results 
in four solvents are summarized.  
The particles obtained without the application of linker are characterized by an enormous dispersion 
of size in water and therefore we decided to modify their structure by the application of linkers. The 
latter structures (a representative one is shown in Figure 6) contain multiple protonation sites, which 
means that they also tend to aggregate in a pH-dependent manner. They may be considered as 
polyionic surfactant-like species.  
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Table 1. DLS results in four solvents. 
No 
Hydrodynamic size [nm] (fraction %) 
Water Methanol Acetone Toluene 
1a 168 (79%), 954 (21%) 144 (100%) 85 (100%) Above 1 µm 
1b 710 (100%) 184 (100%) 399 (100%) 507 (10%) 
1c 485 (100%) 72 (100%) 39 (49%), 81(51%) 194 (36%), 808 (38%) 
1d 74 (47%), 259 (53%) 180 (100%) 96 (100%) 280 (23%), 870 (77%) 
1e 180 (91%), 840 (8%) 170 (100%) 121 (100%) 697 (100%) 
1f 820 (100%) 70 (40%), 337 (60%) 73 (40%), 280 (60%) 560 (40%) 
1g 402 (25%), 930 (75%) 159 (100%) 294 (100%) Above 1 µm 
1i 296 (100%) 65 (100%) 114 (100%) 495 (100%) 
1j 519 (100%) 139 (100%) 294 (100%) Above 1 µm 
2d 177 (28%) 202 (100%) Powyżej 1 µm Above 1 µm 
2g 36 (15%), 116 (85%) 178 (100%) 95 (100%) Above 1 µm 
3a 105 (100%) 120 (78%) 86 (100%) Above 1 µm 
3c 100 (39%), 319 (61%) 130 (100%) 82 (100%) 349 (100%) 
3d 93 (38%), 277 (62%) 109 (100%) 77 (100%) Above 1 µm 
3e 158 (15%), 406 (85%) 82 (22%), 125 (78%) 96 (100%) 377 (58%), 840 (42%) 
3j 630 (100%) 209 (100%) 86 (100%) 635 (100%) 
4d 602 (100%) 196 (100%) 80 (100%) 249 (46%), 748(54%) 
4g 128 (52%), 380 (48%) 150 (100%) 198 (100%) 175 (100%) 
5b 490 (30%), 770 (70%) 71 (100%) 86 (100%) 215 (25%), 743 (75%) 
5g 123 (100%) 130 (18%), 346 (82%) 93 (100%) Above 1 µm 
5h 105 (100%) 118 (100%) 160 (100%) 222 (100%) 
Figure 6. Representative structure of nanoparticle—arrows indicate protonation sites. 
 
Nanoparticles (both esters and acids) gave satisfactory size-dispersion when directly suspended in 
water, being usually in the range of 100 nm. The average sizes of the obtained particles were, however, 
usually higher that those obtained in methanol. Therefore we had measured their dependence on the 
pH of the aqueous solution by applying pH of 2, 6.8 and 12. At neutral pH, a strong tendency to 
aggregation was observed. A representative example obtained is shown in Figure 7. As expected, a 
significant reduction of the average size and size dispersion was obtained in strongly basic (pH 12) 
solutions, where all the residues are unprotonated. Also no aggregation was observed at this pH. More 
complex, and dependent on the chemical structure of aminophosphonate side chain, is the influence 
of acidic pH. In the cases when the aminophosphonate side chain is hydrophobic it usually has a 
positive influence on nanoparticle dispersion. Also in this case it is difficult to draw any 
reasonable structure-behavior relationship.  
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Figure 7. Size distribution of nanoparticles 2g in different pH values. 
 
The stability of nanoparticles dispersions correlates well with the ζ−potential measurements. It is 
generally accepted that the potential higher than 30 meV or lower than −30 meV characterizes stable 
systems. This is also the case in these studies.  
3. Experimental  
3.1. General 
All solvents and reagents were purchased from commercial suppliers (Aldrich, Sigma, Merck, 
POCh), were of analytical grade and were used without further purification. Infrared spectra were 
measured on a 1600 FT-IR Perkin-Elmer spectrometer. The size of the nanoparticles was determined 
by dynamic light scattering using a Malvern Zetasizer Nano ZS in Laboratory of Biomedical 
Chemistry, Department of Experimental Oncology, Institute of Immunology and Experimental 
Therapy, PAS, Wroclaw. NMR experiments were performed on a Bruker DRX AVANCE TM 
300MHz spectrometer. SEM-EDX and TEM analyses were performed in the Microscopy and Analysis 
Suite, University of Bath, on a JEOL JSM6480LV with an Oxford INCA X-ray analyzer and an OEL 
JEM 1200EXII, respectively.  
3.2. The Synthesis of Iron Oxide Nanoparticles Coated with Silica 
To a one-litre three neck flask of water (188 mL) and 23% aqueous solution of ammonia (10 mL) 
was added. The solution was stirred under a nitrogen atmosphere. At the same time a mixture of 
FeCl3·6H2O and FeCl2·4H2O (in a molar ratio of 1:2) was dissolved in water (10 mL) containing 36% 
HCl solution (0.125 mL). This solution of chloride salts was very slowly added dropwise to the solution 
of NH4OH with vigorous stirring. A black precipitate of iron oxide nanoparticles was formed and isolated 
through magnetic decantation. Magnetic nanoparticles were washed several times with distilled water 
and finally with 0.1 M solution of tetramethylammoniun hydroxide (TMAOH, 100 mL). This mixture 
was sonicated for 1 h, and the nanoparticles were isolated through magnetic decantation and dried.  
Iron oxide nanoparticles (0.1 g) were placed in distilled water (100 mL) and sonicated for 1 h.  
Then 2-propanol (100 mL) was added and the mixture sonicated for an additional 3 h. After that 23% 
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aqueous solution of ammonia (1 mL) was added. The mixture was vigorously stirred and 
tetraethylortosilicate (0.2 mL) was added. After 2 h of stirring the nanoparticles were separated 
through magnetic decantation, washed with water and dried. 
3.3. The Functionalization of Silica Coated Nanoparticles with (3-aminopropyl)trimethoxysilane  
Freshly coated iron oxide nanoparticles (0.5 g), water (25 mL) and methanol (25 mL) were placed 
in a flask and sonicated for 1 h. After this time (3-aminepropyl)trimethoxylsilane (0.75 mL) was added 
in one portion and the mixture stirred at 80 °C for 5 h. The brown precipitate was isolated through 
magnetic decantation, washed with water and dried.  
3.4. The General Procedure Followed for the Synthesis of Aminophosphonate-Functionalized 
Magnetic Nanoparticles 
Nanoparticles functionalized surfacially with amino-groups (0.5 g) were mixed with 2-amino-5-
chloropyridine (0.5 g) or 2,6-diamino-4-chloropyrimidine (0.5 g) in toluene and refluxed for 8h. After 
this time, the solvent was evaporated, the precipitate washed with fresh toluene and magnetically decanted. 
The synthesised nanoparticles were then used as amine reagent for the synthesis of aminophosphonates. 
Thus, the appropriate amount of nanoparticles (0.5 g) and aldehyde (1 g) were mixed in toluene and 
refluxed until the amount of collected water remained unchanged in the Dean-Stark trap. The solvent 
was evaporated and the crude nanoparticle Schiff base was used in the next step without purification. It 
was suspended in a new portion of toluene and the equivalent of diethyl phosphite (in 1:1 molar ratio 
to aldehyde) was added followed by refluxing for 4 h. The solvent was then evaporated, the residue 
washed with toluene, and water and isolated through magnetic decantation.  
1a: IR (KBr, cm−1): 570 (m, Fe-O), 1049 (s, P-O-C), 1093 (s, Si-O), 1176 (s, Si-C), 1218 (s, P=O), 
1479 (s, N-H), 1596 (s, CAr-NAr), 2919, 2990 (m, C-H), 3326 (m, Ar-O-H); SEM-EDX (KeV): 0.1 (C), 
0.5 (O), 1.9 (Si), 2.0 (P), 6.7 (Fe). 
1b: IR (KBr, cm−1): 569.8 (m, Fe-O), 1037 (s, P-O-C), 1060 (s, Si-O), 1172 (s, Si-C), 1284 (m, P=O), 1479 
(s, N-H), 1596 (s, CAr-NAr), 2919 (m, C-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 1.9 (Si), 2.0 (P), 6.7 (Fe). 
1c: IR (KBr, cm−1): 541 (m, Fe-O), 1020 (s, P-O-C), 1048 (s, Si-O), 1230 (s, P=O), 1478 (s, N-H), 
1598 (s, CAr-NAr), 2899, (m, C-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 1.9 (Si), 2.0 (P), 6.7 (Fe).  
1d: IR (KBr, cm−1): 567 (m, Fe-O), 1029 (s, P-O-C), 1054 (s, Si-O), 1230 (s, P=O), 1247 (s, Si-C), 
1484 (s, N-H), 1598 (s, CAr-NAr), 2865 (m, C-H), 3285,14 (s, N-H); SEM-EDX (KeV): 0.1 (C), 0.5 
(O), 1.9 (Si), 2.0 (P), 6.7 (Fe).  
1e: IR: (KBr, cm−1): 577 (m, Fe-O), 1022 (s, P-O-C), 1053 (s, Si-O), 1475 (s, N-H), 1598 (s, CAr-NAr), 
2906 (m, C-H), 3294 (m, N-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 1.9 (Si), 2.0 (P), 6.7 (Fe).  
1f: IR: (KBr, cm−1): 533 (m, Fe-O), 1036 (s, P-O-C), 1224 (s, P-O), 1288 (m, Si-C), 1481 (s, N-H), 
1596 (s, CAr-NAr), 2901, 2979 (m, C-H), 3283 (s, N-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 1.9 (Si), 
2.0 (P), 6.7 (Fe).  
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1g: IR (KBr, cm−1): 583 (m, Fe-O), 1032 (s, P-O-C), 1052 (m, Si-C), 1238 (s, P=O), 1369 (m, N-O), 
1481 (m, N-H), 1533 (m, CAr-NAr), 2976 (m, C-H), 3307 (s, N-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 
1.9 (Si), 2.0 (P), 6.7 (Fe).  
1h: IR (KBr, cm−1): 583 (m, Fe-O), 1028 (s, P-O-C), 1028 (m, Si-C), 1238 (s, P=O), 1354 (m, N-O), 
1499 (m, N-H), 1533 (m, CAr-NAr), 2986 (m, C-H), 3419 (s, N-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 
1.9 (Si), 2.0 (P), 6.7 (Fe). 
1i: IR (KBr, cm−1): 568 (m, Fe-O), 1045 (s, P-O-C), 1162 (m, Si-O), 1224 (m, P=O), 1336 (m, N-O), 
1439 (m, N-H), 1508 (m, CAr-NAr), 2982 (m, C-H), 3413 (s, N-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 
1.9 (Si), 2.0 (P), 6.7 (Fe). 
1j: IR (KBr, cm−1): 571 (m, Fe-O), 1096 (s, P-O-C), 1148 (s, Si-O), 1213 (s, P-O), 1246 (s, Si-C), 
1459 (m, N-H), 2832, 2938 (m, C-H), 3187 (m, Ar-O-H), 3240 (s, N-H); SEM-EDX (KeV): 0.1 (C), 
0.5 (O), 1.9 (Si), 2.0 (P), 6.7 (Fe). 
2d: IR (KBr, cm−1): 560 (m, Fe-O), 1051 (s, P-O-C), 1162 (s, Si-O), 1495 (m, N-H), 1579 (s, CAr-NAr), 
2931, 2982, (m, C-H), 3399 (s, N-H); SEM-EDX (KeV): 0.1 (C), 0.5 (O), 1.9 (Si), 2.0 (P), 6.7 (Fe). 
2g: IR (KBr, cm−1): 546 (m, Fe-O), 1049 (s, P-O-C), 1162 (m, Si-O, Si-C), 1296 (m, Ar-O-C), 1467  
(s, N-H), 1579 (s, CAr-NAr), 2980 (m, C-H), 3100 (m, Ar-O-H), 3303 (s, N-H); SEM-EDX (KeV):  
0.1 (C), 0.5 (O), 1.9 (Si), 2.0 (P), 6.7 (Fe). 
3.5. The General Synthesis of Monoesters 
The nanoparticle diester (0.5 g) and the sodium iodide (0.5 g) were placed in acetone and refluxed 
for 3 h. The sodium salt of the monoester was isolated through magnetic decantation, washed with 
acetone and converted into acid form by washing with 1 M HCl. The obtained nanoparticles were 
washed with water and dried. 
3a: R (KBr, cm−1): 577 (m, Fe-O), 1050 (s, P-O-C), 1068 (s, Si-O), 1189 (s, Si-C), 1223 (m, P=O), 
1607 (s, N-H), 1656 (s, CAr-NAr), 2737 (m, C-H), 3257 (m, AO-H), 3417 (s, N-H). 
3b: IR (KBr, cm−1): 570 (m, Fe-O), 1037 (s, P-O-C), 1060 (s, Si-O), 1173 (s, Si-C), 1284 (m, P=O), 
1479 (s, N-H), 1596 (s, CAr-NAr), 2919, 3228 (m, C-H). 
3c: IR (KBr, cm−1): 541 (m, Fe-O), 1012 (s, P-O-C), 1044 (s, Si-O), 1212 (s, P=O), 1473 (s, N-H), 
2849, 2917 (s, C-H), 3429 (m, O-H). 
3d: IR (KBr, cm−1): 569 (m, Fe-O), 1095 (s, P-O-C), 1228 (s, P=O), 1482 (s, N-H), 1598 (s, CAr-NAr), 
3469 (s, O-H). 
3e: IR (KBr, cm−1): 611 (m, Fe-O), 1027 (m, P-O-C), 1054 (m, Si-O), 1479 (m, N-H), 1598 (m,  
CAr-NAr), 3416 (s, O-H). 
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3e: IR (KBr, cm−1): 611 (m, Fe-O), 1027 (m, P-O-C), 1054 (m, Si-O), 1479 (m, N-H), 1598 (m,  
CAr-NAr), 3416 (s, O-H). 
3f: IR: (KBr, cm−1): 536 (m, Fe-O), 1026 (s, P-O-C), 1052 (s, Si-O), 1228 (m, P=O), 1478 (s, N-H), 
1597 (s, CAr-NAr), 2984, (m, C-H), 3468 (s, O-H). 
3g: IR (KBr, cm−1): 546 (m, Fe-O), 1024 (m, P-O-C), 1431 (w, N-H), 1605 (m, CAr-NAr), 3398 (s, O-H). 
3h: IR (KBr, cm−1): 611 (m, Fe-O), 1044 (m, P-O-C), 1162 (M, Si-O, Si-C), 1239 (m, P=O), 1355 (m, 
N-O), 1499 (w, N-H), 3416 (s, N-H), 3468 (s, O-H). 
3i: R (KBr, cm−1): 570 (m, Fe-O), 1047 (m, P-O-C), 1162 (m, Si-O), 1227 (m, P=O), 1336 (m, N-O), 
1440 (w, N-H), 1510 (m, CAr-NAr), 3415 (s, N-H), 3471 (s, O-H). 
3j: IR (KBr, cm−1): 571 (m, Fe-O), 1096 (s, P-O-C), 1148 (s, Si-O), 1213 (s, P=O), 1460 (m, N-H), 
1625 (s, CAr-NAr), 2832, 2938 (m, C-H), 3187 (m, Ar-O-H), 3240 (m, N-H), 3412 (m, O-H). 
4. Conclusions 
Hydrophosphonylation surfacial Schiff bases obtained from iron oxide magnetic nanoparticles 
functionalized with amino groups appeared to be an effective method for preparation of 
aminophosphonate-functionalized nanoparticles. By being surfacially charged (both negative and 
positive) these particles behave as micelles. 
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